This is the first application for renewal of T32 CA193111 to continue funding the training of next generation of physician-scientists in gastrointestinal oncology. We believe that physician-scientists armed with rigorous research training are necessary to discover and translate new advances in GI oncology as well as to investigate critical issues facing delivery of cancer care to patients. Our trainees are drawn from NYU?s renowned clinical fellowship programs in Medical Oncology or Gastroenterology or top-notch residency programs in Radiation Oncology or Surgery. Trainees take a 2-3 year hiatus from clinical activities to engage in intensive full-time training in GI cancer research. Our program is composed of (i) a Basic/Translational Science track aimed at individuals who wish to direct their own basic science laboratory in GI oncology or individuals who want to lead translational research programs that comfortably interface between the pre-clinical laboratory and clinical investigation and (ii) a Population Sciences tract for trainees who seek careers in the diverse fields of population sciences including cancer epidemiology, comparative effectiveness, disparities, health services, or outcomes research. The program for our Basic/Translational Science track consists of two years of individualized mentored research in faculty laboratories, enhanced by a strong parallel didactic program in cancer biology. The Population Sciences track is centered on a rigorous Masters-level curriculum that teaches clinical trial design, epidemiology, comparative-effectiveness, and outcomes research methodologies along with a mentored research project based in population sciences. The two tracks are united through a weekly 2-hour core curriculum covering essential topics in GI cancer and critical lessons for cancer physicians embarking on independent investigative careers. We plan to continue to have a steady-state of 4 trainees at any given time. Our first group of graduates have been very successful in acquiring the research skills and credentials to eventually lead their own research groups. We are proud that our first graduates have obtained academic positions in oncology and submitted highly scored K grants. Our trainees are nurtured by a cadre of mentors with substantial accomplishments in cancer research and stellar training records.
The aim of our training program is to continue to graduate physician- scientists armed with the intellectual capacity and tools to lead their own research programs and become leaders and role models in investigative GI oncology.

Public Health Relevance

A renewal of this T32 program designed to continue training aspiring physician-scientists in GI cancer research. Trainees are drawn from Medical Oncology, Radiation Oncology, Surgery, and Gastroenterology and will enroll in either a Basic/Translational Science track or a Population Science track led by mentors accomplished in both scientific research and training. Our goal is to graduate physician-scientists armed with the capacity and credentials to lead their own innovative research programs and develop into leaders in investigative GI oncology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
2T32CA193111-06
Application #
9937203
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Lim, Susan E
Project Start
2015-07-01
Project End
2025-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
6
Fiscal Year
2020
Total Cost
Indirect Cost
Name
New York University
Department
Surgery
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Wu, Benjamin G; Segal, Leopoldo N (2018) The Road to Precision Medicine in Chronic Obstructive Pulmonary Disease: Squeezing More Out of Chest Computed Tomography Scans. Ann Am Thorac Soc 15:428-429
Wu, Benjamin G; Segal, Leopoldo N (2018) The Lung Microbiome and Its Role in Pneumonia. Clin Chest Med 39:677-689
Tsay, Jun-Chieh J; Wu, Benjamin G; Badri, Michelle H et al. (2018) Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer. Am J Respir Crit Care Med 198:1188-1198
Daley, Donnele; Mani, Vishnu R; Mohan, Navyatha et al. (2017) Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med 23:556-567
Daley, Donnele; Zambirinis, Constantinos Pantelis; Seifert, Lena et al. (2016) ?? T Cells Support Pancreatic Oncogenesis by Restraining ?? T Cell Activation. Cell 166:1485-1499.e15
Seifert, Lena; Werba, Gregor; Tiwari, Shaun et al. (2016) The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature 532:245-9
Seifert, Lena; Werba, Gregor; Tiwari, Shaun et al. (2016) Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice. Gastroenterology 150:1659-1672.e5
Greco, Stephanie H; Torres-Hernandez, Alejandro; Kalabin, Aleksandr et al. (2016) Mincle Signaling Promotes Con A Hepatitis. J Immunol 197:2816-27
Deutsch, M; Graffeo, C S; Rokosh, R et al. (2015) Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury. Cell Death Dis 6:e1759
Seifert, Lena; Deutsch, Michael; Alothman, Sara et al. (2015) Dectin-1 Regulates Hepatic Fibrosis and Hepatocarcinogenesis by Suppressing TLR4 Signaling Pathways. Cell Rep 13:1909-1921

Showing the most recent 10 out of 12 publications